FLGT (STOCKS)
Fulgent Genetics, Inc. Common Stock
$18.350000
-0.330000 (-1.77%)
Prev close: $18.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Ming Hsieh
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $520.30M
- Employees
- 1,313
- P/E (TTM)
- -7.66
- P/B (TTM)
- 0.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.36 | $-0.11 | -0.2529 | -236.13% |
|
Dec 2025 (Q4)
|
$0.16 | $0.03 | +0.1294 | +422.88% |
|
Sep 2025 (Q3)
|
$0.14 | $-0.23 | +0.3678 | +161.46% |
|
Jun 2025 (Q2)
|
$0.07 | $-0.19 | +0.2570 | +137.43% |
Financial Statements
| Revenues | $320.35M |
| Benefits Costs and Expenses | $404.63M |
| Cost Of Revenue | $196.33M |
| Costs And Expenses | $404.63M |
| Gross Profit | $124.02M |
| Nonoperating Income/Loss | $21.64M |
| Operating Expenses | $229.94M |
| Research and Development | $55.69M |
| Other Operating Expenses | $174.26M |
| Operating Income/Loss | -$105.92M |
| Income/Loss From Continuing Operations After Tax | -$75.01M |
| Income/Loss From Continuing Operations Before Tax | -$84.28M |
| Income Tax Expense/Benefit | -$9.27M |
| Income Tax Expense/Benefit, Deferred | -$2.20M |
| Net Income/Loss | -$75.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.20M |
| Net Income/Loss Attributable To Parent | -$73.81M |
| Net Income/Loss Available To Common Stockholders, Basic | -$73.81M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 92,243,000 |
| Diluted Average Shares | 92,243,000 |
| Assets | $1.16B |
| Current Assets | $479.04M |
| Inventory | $770.00K |
| Prepaid Expenses | $5.78M |
| Other Current Assets | $472.49M |
| Noncurrent Assets | $677.33M |
| Fixed Assets | $116.34M |
| Intangible Assets | $153.99M |
| Other Non-current Assets | $406.99M |
| Liabilities | $112.22M |
| Current Liabilities | $90.13M |
| Accounts Payable | $21.13M |
| Other Current Liabilities | $69.01M |
| Noncurrent Liabilities | $22.08M |
| Equity | $1.04B |
| Equity Attributable To Noncontrolling Interest | -$5.66M |
| Equity Attributable To Parent | $1.05B |
| Liabilities And Equity | $1.16B |
| Net Cash Flow From Operating Activities | -$90.11M |
| Net Cash Flow From Operating Activities, Continuing | -$90.11M |
| Net Cash Flow From Investing Activities | $94.58M |
| Net Cash Flow From Investing Activities, Continuing | $94.58M |
| Net Cash Flow From Financing Activities | -$48.45M |
| Net Cash Flow From Financing Activities, Continuing | -$48.45M |
| Exchange Gains/Losses | $97.00K |
| Net Cash Flow | -$43.88M |
| Net Cash Flow, Continuing | -$43.98M |
| Comprehensive Income/Loss | -$74.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$1.25M |
| Comprehensive Income/Loss Attributable To Parent | -$73.61M |
| Other Comprehensive Income/Loss | $151.00K |